Department of Otolaryngology-Head & Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Cochlear Center for Hearing and Public Health, Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
J Gerontol A Biol Sci Med Sci. 2022 Mar 3;77(3):640-646. doi: 10.1093/gerona/glab153.
Hearing loss is prevalent and associated with adverse functional outcomes in older adults. Prevention thus has far-reaching implications, yet few modifiable risk factors have been identified. Hypertension may contribute to age-related hearing loss, but epidemiologic evidence is mixed. We studied a prospective cohort of 3343 individuals from the Atherosclerosis Risk in Communities study, aged 44-65 years at baseline with up to 30 years of follow-up.
Hearing was assessed in late life (2016-2017) using a better-ear audiometric pure tone average (0.5, 1, 2, 4 kHz) and the Quick Speech-in-Noise (QuickSIN) test. Hypertension was defined as systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or antihypertensive medication use. Midlife hypertension was defined by hypertension at 2 consecutive visits between 1987-1989 and 1996-1998. Late-life hypertension was defined in 2016-2017. Late-life low blood pressure was defined as a systolic blood pressure less than 90 mmHg or diastolic blood pressure less than 60 mmHg, irrespective of antihypertensive medication use. Associations between blood pressure patterns from mid- to late life and hearing outcomes were assessed using multivariable-adjusted linear regression.
Compared to persistent normotension, persistent hypertension from mid- to late life was associated with worse central auditory processing (difference in QuickSIN score = -0.66 points, 95% CI: -1.14, -0.17) but not with audiometric hearing.
Participants with persistent hypertension had poorer late-life central auditory processing. These findings suggest that hypertension may be more strongly related to hearing-related changes in the brain than in the cochlea.
听力损失在老年人中较为普遍,并与不良功能结局相关。因此,预防具有深远的意义,但尚未确定多少种可改变的危险因素。高血压可能与年龄相关性听力损失有关,但流行病学证据不一。我们研究了一个前瞻性队列,该队列来自动脉粥样硬化风险社区研究,共有 3343 名年龄在 44-65 岁、基线时有 30 年随访的个体。
在生命晚期(2016-2017 年)使用更好耳听力纯音平均(0.5、1、2、4 kHz)和快速语音噪声测试(QuickSIN)来评估听力。高血压定义为收缩压≥140mmHg、舒张压≥90mmHg 或使用抗高血压药物。中年高血压定义为在 1987-1989 年和 1996-1998 年连续两次就诊时患有高血压。晚期高血压在 2016-2017 年被定义。晚期低血压定义为收缩压<90mmHg 或舒张压<60mmHg,无论是否使用抗高血压药物。使用多变量调整线性回归评估从中年到晚期的血压模式与听力结果之间的关联。
与持续正常血压相比,从中年到晚期持续高血压与中央听觉处理能力下降相关(QuickSIN 评分差异=-0.66 分,95%CI:-1.14,-0.17),但与听力无关。
持续高血压的参与者在生命晚期的中央听觉处理能力较差。这些发现表明,高血压与大脑中的听力变化关系可能比耳蜗中的听力变化关系更为密切。